Feb 04, 2009
Over 70 members of the four international teams funded through the National MS Society’s Promise: 2010 Campaign met in New York City in January to share progress, forge new collaborations, and plan future steps to speed efforts toward clinical trials of therapies to protect and reverse neurological damage in people with multiple sclerosis.
With the Society’s pledged funding of $15.6 million for five years, the teams have been conducting a broad range of studies aimed at protecting and reversing neurological damage – from basic molecular studies to planning clinical trials.Read complete article from the National MS Society
Posting comments can be beneficial to others and it allows you to express yourself.
If you have a statement or question pertaining to this article, this is the place to leave it.
Click the link below the article that reads: Post Comments. - Thank You